iiinova — where your digital self keeps evolving

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 30/01/2026

Present & future directions of metastatic #ProstateCancer treatment LISTEN HERE 👉 www.buzzsprout.com/1555850/epis... In this episode of @uroweb.org Podcast Dr. Pawel Rajwa 🇵🇱sits down with Dr. @silkegillessen.bsky.social 🇨🇭to discuss where metastatic prostate cancer treatment stands

011

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 15/04/2025

Racial disparities in #ProstateCancer in the UK and the USA nature.com/articles/s41... paper emphasizes that addressing these inequities requires systemic change: dismantling structural racism, increasing representation in clinical research and healthcare workforce @silkegillessen.bsky.social

032

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 19/03/2025

Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial t.co/tzTr4MmoZi TRAP Results showed a median progression-free survival (PFS) of 6.4 months, with 39% of patients maintaining PFS beyond 12 months.

064

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 11/03/2025

Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and Their Prognostic Value in Radical Prostatectomy jnm.snmjournals.org/content/66/3... The results suggest intraoperative ex vivo PET/CT could be useful for margin assessment, though further trials are needed. #ProstateCancer

032

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 11/02/2025

Physics-Informed Autoencoder for Prostate Tissue Microstructure Profiling with Hybrid Multidimensional MRI pubs.rsna.org/doi/full/10.... #ProstateCancer @barbaramelao.bsky.social @achoud72.bsky.social @yukselurun.bsky.social @drnataliagandur.bsky.social

011

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 07/02/2025

High-purity CTC RNA sequencing identifies #ProstateCancer lineage phenotypes prognostic for clinical outcomes out in CANCER DISCOVERY aacrjournals.org/cancerdiscov... @silkegillessen.bsky.social @aureliusomlin.bsky.social @barbaramelao.bsky.social @achoud72.bsky.social @yukselurun.bsky.social

0126

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 17/01/2025

Cancer Statistics Just Out for 2025 out on American Cancer Society Journals acsjournals.onlinelibrary.wiley.com/doi/epdf/10.... #ProstateCancer has one of the highest contemporary survival rates at 97%, followed closely by testicular cancer (95%) and melanoma (94%)

084

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 31/12/2024

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial europeanurology.com/article/S030... Results provide valuable insights for treatment decision-making, highlighting better urinary and sexual outcomes with SBRT

092

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 18/12/2024

AR alterations inform circulating tumor DNA detection in metastatic castration resistant #ProstateCancer patients out in Nature Communications www.nature.com/articles/s41... Highlights ctDNA positivity as a strong prognostic marker for poor survival in mCRPC, even with AR inhibitor treatments.

071

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 09/12/2024

Study investigates how androgen-dependent #ProstateCancer evades immune detection by downregulating major histocompatibility complex class I.The researchers found that late-stage prostate cancer responds better to immunotherapy when MHCI expression is elevated aacrjournals.org/cancerdiscov...

141

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 05/12/2024

A warm welcome to Dr. Aurelius Omlin🇨🇭@aureliusomlin.bsky.social to BlueSky! Medical Uro-Oncologist & Co-Organiser of international Advanced Prostate Cancer Consensus Conference (APCCC) in Lugano🇨🇭 @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

082

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 04/12/2024

Simulation of Focal Boosting in Online Adaptive MRI-Guided SBRT in Locally Advanced #ProstateCancer w/Seminal Vesicle Involvement MRI guidance was effective in delivering precise tx despite constraints www.practicalradonc.org/article/S187... @achoud72.bsky.social @barbaramelao.bsky.social

062

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 03/12/2024

Study used 2sample Mendelian randomization approach to investigate the causal relationship between various dietary habits and #ProstateCancer risk bmccancer.biomedcentral.com/articles/10.... @oncoalert.bsky.social @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social

063

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 03/12/2024

A warm welcome to APC Society President Dr. Silke Gillessen @silkegillessen.bsky.social To BlueSky Director of the Oncology Institute of S. Switzerland🇨🇭& Head of Dpt of Medical Oncology @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

093

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 02/12/2024

Frailty in Older Adults with #ProstateCancer euoncology.europeanurology.com/article/S258... Tailored tx, including geriatric interventions & supportive care, are crucial for frail patients @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

1116

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 20/11/2024

Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized #ProstateCancer Undergoing ADT With Rad tx Findings suggest variability in ADT’s hypoxia-modifying effects might undermine the biomarkers’ predictive utility. @achoud72.bsky.social www.redjournal.org/article/S036...

074